Stugeron

CAS No. 298-57-7

Stugeron( Cinnarizine | Stugeron | Dimitronal | Stutgin | Dimitron | Folcodal | Dihydrochloride Cinnarizine | Dimitronal )

Catalog No. M13913 CAS No. 298-57-7

Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Stugeron
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker.
  • Description
    Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cinnarizine | Stugeron | Dimitronal | Stutgin | Dimitron | Folcodal | Dihydrochloride Cinnarizine | Dimitronal
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel| H1 receptor
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    298-57-7
  • Formula Weight
    368.51
  • Molecular Formula
    C26H28N2
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
  • Chemical Name
    1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Terland O, et al. Neuropharmacology. 1999 Jun;38(6):879-82.
molnova catalog
related products
  • OPC 8490 free base

    OPC 8490 free base is a novel positive inotropic vasodilator and a cardiotonic agent that increases Ca currents in a dose-dependent and reversible manner and can be used to study cardiovascular diseases.

  • TTA-Q6

    TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.

  • Gallopamil

    Gallopamil inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 μM.